Similar articles

• Incorporating first-trimester Down syndrome studies into prenatal screening: executive summary of the National Institute of Child Health and Human Development workshop.

  Reddy UM, Mennuti MT. Reddy UM, et al. Obstet Gynecol. 2006 Jan;107(1):167-73. doi: 10.1097/01.AOG.0000194186.34664.a9. Obstet Gynecol. 2006. PMID: 16394055
• Options for Down syndrome screening: what will women choose?

  Grant SS. Grant SS. J Midwifery Womens Health. 2005 May-Jun;50(3):211-8. doi: 10.1016/j.jmwh.2005.01.008. J Midwifery Womens Health. 2005. PMID: 15894999 Review.
• Sequential pathways of testing after first-trimester screening for trisomy 21.

  Malone FD. Malone FD. Obstet Gynecol. 2005 Feb;105(2):438; author reply 438-9. doi: 10.1097/01.AOG.0000153257.08966.f9. Obstet Gynecol. 2005. PMID: 15684179 No abstract available.
• [Systematic proposal and obligation of information in Down syndrome screening].

  Grangé G, Azria E. Grangé G, et al. J Gynecol Obstet Biol Reprod (Paris). 2008 Oct;37(6):535-7. doi: 10.1016/j.jgyn.2008.07.004. Epub 2008 Aug 28. J Gynecol Obstet Biol Reprod (Paris). 2008. PMID: 18760548 French. No abstract available.
• Low MSAFP and new biochemical markers for Down syndrome: implications for genetic counselors.

  Kloza EM. Kloza EM. Birth Defects Orig Artic Ser. 1990;26(3):31-43. Birth Defects Orig Artic Ser. 1990. PMID: 1709365 No abstract available.